Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est
Benzinga Newsdesk 3 months ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 analyst estimate. Narrows FY2026 sales outlook from $220.000 million-$226.000 million to $220.000
Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 analyst estimate. Narrows FY2026 sales outlook from $220.000 million-$226.000 million to $220.000 million-$222.000 million vs $223.449 million estimate.